- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02740491
Implementation of a "Remission" Consultation in the Management of Patients Treated for Localized Breast Cancer (REVIS)
Evaluation of the Implementation of a "Remission" Consultation in the Management of Patients Treated for Localized Breast Cancer
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The secondary objectives of this study are:
A. to describe changes in body image (Image Body Scale Version F) at 3, 6 and 12 months after a "remission" consultation.
B. to describe changes in psychological distress (visual analog scale) at 3, 6 and 12 months after a "remission" consultation.
C. to assess the time of resumption of work (date of last chemotherapy - date of the actual resumption of work) after a "remission" consultation.
D. to evaluate the acceptance rate for the "remission" consultation.
E. to describe the modes of the observed management, their distribution and the characteristics of the patients according to different monitoring arrangements.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
-
Nîmes Cedex 09, Frankrig, 30029
- CHRU de Nîmes - Hôpital Universitaire Carémeau
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- The patient is receiving care for localized breast cancer and finished her adjuvant treatment (chemotherapy, radiotherapy)
- The patient has completed his/her adjuvant therapy in the last 6 months (chemotherapy, radiotherapy).
Exclusion Criteria:
- The patient is participating in another study
- The patient is under judicial protection
- It is impossible to correctly inform the patient
- The patient has a metastatic form of the disease at diagnosis
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kun etui
- Tidsperspektiver: Fremadrettet
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
---|---|
The study population
The study population consists of adult patients diagnosed with localized breast cancer who have completed adjuvant treatment (chemotherapy, radiotherapy) and who are cared for in the Medical Oncology department of the Nîmes University Hospital.
|
At the end of adjuvant treatment (adjuvant chemotherapy and / or radiotherapy), the patient is seen by a referent oncologist and included in the study. A "Remission" consultation with a psychotherapist is then proposed and its purpose explained to the patient. The patient agrees or refuses take advantage of the "Remission" consultation; in case of refusal, the reasons are documented and further information is provided, thus giving the opportunity for the patient to benefit from further psychological counseling if desired. If approval is given, the patient will be scheduled for the "Remission" consultation (duration 1 hour) . The latter includes a first phase evaluating the mental state of the patient, and then a proposal of individualized care if necessary and according to several methods, depending on the choice of the patient. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
The EORTC QLQ-C30 questionnaire
Tidsramme: Day 0
|
Day 0
|
The EORTC QLQ-C30 questionnaire
Tidsramme: Month 3
|
Month 3
|
The EORTC QLQ-C30 questionnaire
Tidsramme: Month 6
|
Month 6
|
The EORTC QLQ-C30 questionnaire
Tidsramme: Month 12
|
Month 12
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Body Image Scale
Tidsramme: Day 0
|
Day 0
|
Body Image Scale
Tidsramme: Month 3
|
Month 3
|
Body Image Scale
Tidsramme: Month 6
|
Month 6
|
Body Image Scale
Tidsramme: Month 12
|
Month 12
|
Psychological distress (visual analog scale)
Tidsramme: Day 0
|
Day 0
|
Psychological distress (visual analog scale)
Tidsramme: Month 3
|
Month 3
|
Psychological distress (visual analog scale)
Tidsramme: Month 6
|
Month 6
|
Psychological distress (visual analog scale)
Tidsramme: Month 12
|
Month 12
|
Work recovery time (date of last chemotherapy - date of the actual resumption of work)
Tidsramme: Month 3
|
Month 3
|
Work recovery time (date of last chemotherapy - date of the actual resumption of work)
Tidsramme: Month 6
|
Month 6
|
Work recovery time (date of last chemotherapy - date of the actual resumption of work)
Tidsramme: Month 12
|
Month 12
|
Acceptance of remission consultation (yes/no)
Tidsramme: Day 0
|
Day 0
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- LOCAL/2016/LD-01
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Brystneoplasmer
-
Guangzhou First People's HospitalAfsluttet
-
Cairo UniversityIkke rekrutterer endnu
-
Abouqir General HospitalAlexandria UniversityRekrutteringBreast Udseende Rekonstruktion DisproportionEgypten
-
ETOP IBCSG Partners FoundationAfsluttetBreast Cancer Invasive NosItalien
-
Spanish Breast Cancer Research GroupHoffmann-La Roche; Roche Farma, S.AAfsluttetBreast Cancer Invasive NosSpanien
-
Tianjin Medical University Cancer Institute and...Guangxi Medical University; Sun Yat-sen University; Chinese PLA General Hospital og andre samarbejdspartnereAfsluttetDen kliniske anvendelsesvejledning af Conebeam Breast CTKina
-
Ontario Clinical Oncology Group (OCOG)Afsluttet
-
Pomeranian Medical University SzczecinMaria Sklodowska-Curie National Research Institute of Oncology; Regional...UkendtBRCA1 mutation | Breast Cancer Invasive NosPolen
-
Aga Khan UniversityAfsluttetBrystkræft | Perforatorklap | Brysttumor | Oncoplasty | Breast-QPakistan
-
University Health Network, TorontoAfsluttetBreast Cancer Invasive Nos | Primær invasiv brystkræftCanada
Kliniske forsøg med Remission Consultation
-
Saint John's Cancer InstituteTrukket tilbageKræft | Omsorgspersoner | Kliniske forsøgForenede Stater
-
American Institutes for ResearchWisconsin Center for Education Research; University of Nebraska College...RekrutteringFølelsesmæssige forstyrrelserForenede Stater
-
Anna HooverNational Institute of Environmental Health Sciences (NIEHS)RekrutteringDesinfektionsbiprodukterForenede Stater
-
IWK Health CentreThe Hospital for Sick Children; Alberta Children's Hospital; Stollery Children...AfsluttetPædiatrisk colitis ulcerosa | Pædiatrisk Crohns sygdom
-
Chinese University of Hong KongAfsluttet
-
Shengjing HospitalAfsluttet
-
University of PittsburghAfsluttetMyositis | Dermatomyositis | PolymyositisForenede Stater
-
Sint MaartenskliniekRekruttering
-
University of Wisconsin, MadisonAfsluttetFedme | Diabetes | Insulin resistensForenede Stater